Association between the serotonin transporter gene (5-HTTLPR) and anger-related traits in Korean schizophrenic patients

Neuropsychobiology

Volumn 59, Issue 3, 2009, Pages 165-171

  Kim, Youl Ri ^a   Jahng, Jeong Won ^b   Min, Sung Kil ^c  

^a Inje University College of Medicine   (South Korea)

^b School of Dentistry   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

5 HTTLPR; Aggression; Anger; Schizophrenia

Indexed keywords

CHLORPROMAZINE; SEROTONIN TRANSPORTER;

ADULT; AGGRESSION; ALLELE; ANGER; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GENETIC TRAIT; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; STATE TRAIT ANXIETY INVENTORY;

ADULT; AGGRESSION; ALLELES; ANALYSIS OF VARIANCE; ANGER; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEQUENCE ANALYSIS, DNA; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 65549146927     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218079     Document Type: Article

References (33)

1. Krakowski M, Volavka J, Brizer D: Psychopathology and violence - a review of literature. Compr Psychiatry 1986; 27: 131-148.
2. Song H, Min SK: Aggressive behavior model in schizophrenia patients. Psychiatry Res, in press.
3. Cheung P, Schweitzer I, Crowley K, Tuckwell V: Aggressive behaviour in schizophrenia: role of state versus trait factors. Psychiatry Res 1997; 72: 41-50.
4. Nelson RJ, Trainor BC: Neural mechanisms of aggression. Nat Rev Neurosci 2007; 8:536- 546.
5. Barkan T, Peled A, Modai I, Barak P, Weizman A, Rehavi M: Serotonin transporter characteristics in lymphocytes and platelets of male aggressive schizophrenia patients compared to non-aggressive schizophrenia patients. Eur Neuropsychopharmacol 2006; 16:572-579.
6. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP: Allelic variation of human serotonin transporter gene expression. J Neurochem 1996; 66:2621-2624.
7. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL: Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-1531.
8. Schinka JA, Busch RM, Robichaux-Keene N: A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Mol Psychiatry 2004; 9:197-202.
9. Li D, He L: Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behavior. Mol Psychiatry 2007; 12: 47-54.
10. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R: Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301: 386-389.
11. Nolan KA, Volavka J, Lachman HM, Saito T: An association between a polymorphism of the tryptophan hydroxylase gene and aggression in schizophrenia and schizoaffective disorder. Psychiatr Genet 2000; 10:109- 115.
12. Kay SR: Positive and Negative Symptoms in Schizophrenia. New York, Brunner/Mazel, 1991.
13. Kay SR, Wolkenfeld F, Murrill LM: Profiles of aggression among psychiatric patients. 2. Covariates and predictors. J Nerv Ment Dis 1988; 176:547-557.
14. Spielberger CD: State-Trait Anger Expression Inventory. Odessa, Psychological Assessment Resources, 1991.
15. Chon KK: Development of the Korean State-Trait Anger Expression Inventory. KJRP 1996; 3:53-69.
16. Ritsner M, Maayan R, Gibel A, Strous RD, Modai I, Weizman A: Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients. Eur Neuropsychopharm 2004; 14: 267-273.
17. Nickel MK, Muehlbacher M, Nickel C, Kettler C, Gil FP, Bachler E, Egger C, Anvar J, Rother WK, Loew TH, Kaplan P: Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study. Am J Psychiatry 2006; 163:833-838.
18. Yudofsky SC, Silver JM, Jackson W, Endicott J, Williams D: The overt aggression scale for the objective rating of verbal and physical aggression. Am J Psychiatry 1986; 14 3: 35-39.
19. Brummett BH, Muller CL, Collins AL, Boyle SH, Kuhn CM, Siegler IC, Williams RB, Ashley-Koch A: 5-HTTLPR and gender moderate changes in negative affect responses to tryptophan infusion. Behav Genet 2008; 38: 476-483.
20. Davis JM, Chen N: Dose response and dose equivalence of antipsychotics. J Clin Psychopharmacol 2004; 24:192-208.
21. Canli T, Qiu M, Omura K, Congdon E, Haas BW, Amin Z, Herrmann MJ, Constable RT, Lesch KP: Neural correlates of epigenesis. Proc Natl Acad Sci USA 2006; 103:16033-16038.
22. Heinz A, Braus DF, Smolka MN, Wrase J, Puls I, Hermann D, Klein S, Grusser SM, Flor H, Schumann G, Mann K, Buchel C: Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci 2005; 8:20-21.
23. Brocke B , Armbr u ster D, Muller J, Hensch T, Jacob CP, Lesch KP, Kirschbaum C, Strobel A: Serotonin transporter gene variation impacts innate fear processing: acoustic startle response and emotional startle. Mol Psychiatry 2006; 11:1106 -1112.
24. Kennedy HG: Anger and irritability. Br J Psychiatry 1992; 161: 145-153.
25. Min SK, Kim KH: Symptoms of hwabyung. J Korean Neuropsychiatr Assoc 1998; 37:1138-1148.
26. Koen L, Kinnear CJ, Corfield VA, Coorfield RA, Emsley E, Jordaan N, Keyter N, Moolman-Smook JC, Stein DJ, Niehaus DJ: Violence in male patients with schizophrenia: risk markers in a South African population. Aust NZ J Psychiatry 2004; 38:254-259.
27. Connor DF, Boone RT, Steingard RJ, Lopez ID, Melloni RH: Psychopharmacology and aggression. 1. A meta-analysis of non-stimulant medication effects on overt aggression-related behaviors in youth with SED. J Emot Behav Disord 2003; 11: 157-168.
28. Swann AC: Neuroreceptor mechanisms of aggression and its treatment. J Clin Psychiatry 2003; 64: 26-35.
29. Tyrer P, Oliver-Africano PC, Ahmed Z, Bouras N, Cooray S, Deb S, Murphy D, Hare M, Meade M, Reece B, Kramo K, Bhaumik S, Harley D, Regan A, Thomas D, Rao B, North B, Eliahoo J, Karatela S, Soni A, Crawford M: Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial. Lancet 2008; 371:57-63.
30. Vartiainen H, Tiihonen J, Putkonen A, Koponen H, Virkkunen M, Hakola P, Lehto H: Citalopram, a selective serotonin reuptake inhibitor, in the treatment of aggression in schizophrenia. Acta Psychiatr Scand 1995; 91: 348-351.
31. Uher R, McGuffin P: The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis. Mol Psychiatry 2008; 13:131-146.
32. Arranz MJ, Munro J, Birkett J, Bolonna A, Mancama D, Sodhi M, Lesch KP, Meyer JFW, Sham P, Collier DA, Murray RM, Kerwin RW: Pharmacogenetic prediction of clozapine response. Lancet 2000; 355:1615- 1616.
33. Ka iser R, Tremblay PB, Schmider J, Henneken M, Dettling M, Müller-Oerlinghausen B, Uebelhack R, Roots I, Brockmöller J: Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia. Mol Psychiatry 2001; 6:179-185.